Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (-)-bilobalide
1. 33570-04-6
2. Bilobalid
3. (-)-bilobalide
4. Bilobalide A
5. Chebi:3103
6. M81d2o8h7u
7. (3as,8r,8as,9r,10as)-9-tert-butyl-8,9-dihydroxydihydro-9h-furo[2,3-b]furo[3',2':2,3]cyclopenta[1,2-c]furan-2,4,7(3h,8h)-trione
8. 4h,5ah,9h-furo(2,3-b)furo(3',2':2,3)cyclopenta(1,2-c)furan-2,4,7(3h,8h)-trione, 9-(1,1-dimethylethyl)-10,10a-dihydro-8,9-dihydroxy-, (3as,5ar,8r,8as,9r,10as)-
9. 4h,5ah,9h-furo[2,3-b]furo[3',2':2,3]cyclopenta[1,2-c]furan-2,4,7(3h,8h)-trione, 9-(1,1-dimethylethyl)-10,10a-dihydro-8,9-dihydroxy-, (3as,5ar,8r,8as,9r,10as)-
10. Tert-butyl(dihydroxy)[?]trione
11. Unii-m81d2o8h7u
12. (?)-bilobalide
13. Bilobalide [mi]
14. Bilobalide [who-dd]
15. Mls000563448
16. Schembl285824
17. Gtpl2366
18. Chembl1318117
19. Dtxsid10873207
20. Hms2205o12
21. Bcp28255
22. Ex-a6793
23. Hy-n0076
24. Zinc8679998
25. Mfcd00238547
26. Akos024282583
27. Ccg-208160
28. Cs-1517
29. Ncgc00142501-01
30. Ncgc00142501-02
31. 4h,5ah,9h-furo(2,3-b)furo(3',2':2,3)cyclopenta(1,2-c)furan-2,4,7(3h,8h)-trione, 9-(1,1-dimethylethyl)-10,10a-dihydro-8,9-dihydroxy-, (5ar-(3as*,5aalpha,8beta,8as*,9alpha,10aalpha))-
32. As-17551
33. Smr000232342
34. N1894
35. Bilobalide (constituent Of Ginkgo) [dsc]
36. 570b046
37. Q418459
38. Sr-01000712074
39. Q-100409
40. Sr-01000712074-4
41. (-)-bilobalide From Ginkgo Biloba Leaves, >=93% (hplc)
42. (1s,4r,7r,8s,9r,11s)-9-tert-butyl-7,9-dihydroxy-3,5,12-trioxatetracyclo[6.6.0.0^{1,11}.0^{4,8}]tetradecane-2,6,13-trione
43. (1s,4r,7r,8s,9r,11s)-9-tert-butyl-7,9-dihydroxy-3,5,12-trioxatetracyclo[6.6.0.01,11.04,8]tetradecane-2,6,13-trione
44. 4h,5ah,9h-furo[2,3-b]furo[3',2':2,3]cyclopenta[1,2-c]furan-2,4,7(3h,8h)-trione, 9-(1,1-dimethylethyl)-10,10a-dihydro-8,9-dihydroxy-,(3as,5ar,8r,8as,9r,10as)-
Molecular Weight | 326.30 g/mol |
---|---|
Molecular Formula | C15H18O8 |
XLogP3 | -0.3 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 1 |
Exact Mass | 326.10016753 g/mol |
Monoisotopic Mass | 326.10016753 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 650 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Bilobalide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bilobalide, including repackagers and relabelers. The FDA regulates Bilobalide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bilobalide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bilobalide supplier is an individual or a company that provides Bilobalide active pharmaceutical ingredient (API) or Bilobalide finished formulations upon request. The Bilobalide suppliers may include Bilobalide API manufacturers, exporters, distributors and traders.
Bilobalide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bilobalide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bilobalide GMP manufacturer or Bilobalide GMP API supplier for your needs.
A Bilobalide CoA (Certificate of Analysis) is a formal document that attests to Bilobalide's compliance with Bilobalide specifications and serves as a tool for batch-level quality control.
Bilobalide CoA mostly includes findings from lab analyses of a specific batch. For each Bilobalide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bilobalide may be tested according to a variety of international standards, such as European Pharmacopoeia (Bilobalide EP), Bilobalide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bilobalide USP).
LOOKING FOR A SUPPLIER?